Download presentation
1
Hypoglycemia in the infant and childh
2
It is a medical emergency
demanding immediate investigation and treatment
3
Definition of Hypoglycemia
Plasma glucose value of less than 50mg/dl(2.8 MMOL/Lit) Lower limit acceptable during therapy for Hypoglycemia is 70 mg/dl(the goal of Therapy is to maintain plasma glucose levels in the normal range of mg/dl most of time )
7
Symptoms and signs Adrenergic manifestation
Nevro glycopenic manifestation
8
Adrenergic manifestation
Sweating Shakiness Tachycardia Anxiety Weakness Hanger Naseua-vometing
9
Nevroglycopenia manifestation
Headache Visual disturbances Lethargy Mental confusion Convulsion Hypothermia
11
Major causes of Hypo glicemia in the infant and childh
12
Hyper insulinism Aut.R(newborn period) AUT.D(infancy and childhood)
With hyperammonia (infancy and childhood) Glucokinax activation(aut.D) SCHAD(loss of function mutation) Exercise Factitious Insulinoma Auto immune
15
Criteria for diagnosing Hyper insulinism based on critical sample
Detectable insulin (>2MIU/ML) Low FFA(<1.5 MMOL/LIT) Low ketons of plaama(<2.0 MMOL/ML) Glgcemic response to 1mg intravenous glucagon at the time of fasting Hypoglycemia(≥30mg/dl glucose rising in 20 min)
16
Ketotic Hypoglycemia The most common form of childhood Hypoglycemia
Begins between 18 months to 5 years and spontaneous remits by the age of 8-9 years Low plasma alanine level Decrease glucose production during over night fasting Low insulin level-keton body elevated High level of counter regulatory hormones Most patients are smaller than age-match control and have a history of transient neonatal Hypoglycemia
17
Hormone deficiency GH deficiency due to panhypopitutrism
ACTH deficiency due to panhypopitutrism
18
Metabolic disease GSD disorder Galactosemia Organic acidemia
Gluconeogenesis defect ß oxidation defect Fructose intolerance
19
Systemic disease Sepsis Head injury Acute hepatic failure
Multiple organe failure cyanotic congenital heart disease CHF CRF Diarrhea Malaria
20
Drugs Ethanol Beta blocker Acetaminophen Salicylate Sulfanamid Quinine
Co-TMX Pentamidine
21
Alimentary Hypoglycemia(late dumping)
In patient with nissen fundoplication and gastrostomy tube replacement Hypoglycemia & hyperinsulinism 1-2 hours after feeding Treatment consist of acarbose-cachanel blocker octerotide-complex carbohydrate formula
22
Treatment Drug diazoxide
D/W 15% 2-4 cc/kg state fallow by 6-8 mg/ng/min عوارض پرموئی تهوع هیپراورسیمی افزایش سن استخوانی افت فشار کاهش I9G
23
octerotide هر 6-12 ساعت 20 U /kg /day
عوارض: ترشح تهوع – استفراغ اسهال هپاتیت سنگ کیسه صفرا درد محل تزریق surgery
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.